SMTL ID : 3ggu.1

HIV PR drug resistant patient's variant in complex with darunavir

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.80 Å

Oligo State

homo-dimer

Ligands

1 x 017: (3R,3AS,6AR)-HEXAHYDROFURO[2,3-B]FURAN-3-YL(1S,2R)-3-[[(4-AMINOPHENYL)SULFONYL](ISOBUTYL)AMINO]-1-BENZYL-2-HYDROXYPROPYLCARBAMATE(Non-covalent)

017.1: 23 residues within 4Å: Chain A: R.8, D.25, G.27, A.28, D.29, D.30, V.32, G.48, G.49, I.50, P.81, T.82, V.84 Chain B: L.23, D.25, G.27, A.28, D.29, D.30, G.48, G.49, I.50, T.82 21 PLIP interactions: 10 interactions with chain B, 11 interactions with chain A Hydrophobic interactions: B:L.23, B:I.50, A:A.28, A:V.32, A:P.81, A:V.84 Hydrogen bonds: B:D.25, B:G.27, B:G.27, B:D.29, B:D.30, A:D.29, A:D.30, A:D.30, A:D.30, A:I.50 Water bridges: B:I.50, B:I.50, A:R.8 Salt bridges: B:D.25, A:D.25

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Saskova, K.G. et al., Molecular characterization of clinical isolates of human immunodeficiency virus resistant to the protease inhibitor darunavir. J.Virol. (2009)

Release Date

2009-08-11

Peptides

Protease: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

Protease